Optimization of the methods for small peptide solution structure determination by NMR spectroscopy

Molecular Biology

Volumn 44, Issue 6, 2010, Pages 958-967

  Istrate, A N ^a   Mantsyzov, A B ^a   Kozin, S A ^b,c   Polshakov, V I ^a  

^a MOSCOW STATE UNIVERSITY   (Russian Federation)

^b INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^c ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

Author keywords

amyloid; Alzheimer disease; molecular dynamics; NMR spectroscopy; peptide structure

Indexed keywords

RATTUS;

EID: 78649999322     PISSN: 00268933     EISSN: 16083245     Source Type: Journal    
DOI: 10.1134/S0026893310060130     Document Type: Article

References (40)

1. Aguzzi A., O'Connor T. 2010. Protein aggregation diseases: Pathogenicity and therapeutic perspectives. Nature Rev. Drug Discov. 9, 237-248.
2. Grigorenko A. P., Rogaev E. I. 2007. Molecular basis of Alzheimer's disease. Mol. Biol. (Moscow) 41, 294-307.
3. Glenner G. G., Wong C. W. 1984. Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril protein. Biochem. Biophys. Res. Commun. 122, 1131-1135.
4. Masters C. L., Simms G., Weinman N. A., Multhaup G., McDonald B. L., Beyreuther K. 1985. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. USA. 82, 4245-4249.
5. Haass C., Schlossmacher M. G., Hung A. Y., Vigo-Pelfrey C., Mellon A., Ostaszewski B. L., Lieberburg I., Koo E. H., Schenk D., Teplow D. B., et al. 1992. Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature. 359, 322-325.
6. Toropygin I. Y., Kugaevskaya E. V., Mirgorodskaya O. A., Elisseeva Y. E., Kozmin Y. P., Popov I. A., Nikolaev E. N., Makarov A. A., Kozin S. A. 2008. The N-domain of angiotensin-converting enzyme specifically hydrolyzes the Arg-5-His-6 bond of Alzheimer's Abeta-(1-16) peptide and its isoAsp-7 analogue with different efficiency as evidenced by quantitative matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 22, 231-239.
7. Mayeux R., Tang M. X., Jacobs D. M., Manly J., Bell K., Merchant C., Small S. A., Stern Y., Wisniewski H. M., Mehta P. D. 1999. Plasma amyloid beta-peptide 1-42 and incipient Alzheimer's disease. Rapid Commun. Mass Spectrom. 22, 412-416.
8. Seubert P., Vigo-Pelfrey C., Esch F., Lee M., Dovey H., Davis D., Sinha S., et al. 1992. Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids. Nature. 359, 325-327.
9. Hardy J., Selkoe D. J. 2002. The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science. 297, 353-356.
10. Luhrs T., Ritter C., Adrian M., Riek-Loher D., Bohrmann B., Dobeli H., Schubert D., Riek R. 2005. 3D structure of Alzheimer's amyloid-beta(1-42) fibrils. Proc. Natl. Acad. Sci. USA. 102, 17342-17347.
11. Oyler N. A., Tycko R. 2004. Absolute structural constraints on amyloid fibrils from solid-state NMR spectroscopy of partially oriented samples. J. Am. Chem. Soc. 126, 4478-4479.
12. Petkova A. T., Yau W. M., Tycko R. 2006. Experimental constraints on quaternary structure in Alzheimer's beta-amyloid fibrils. Biochemistry. 45, 498-512.
13. Guilloreau L., Damian L., Coppel Y., Mazarguil H., Winterhalter M., Faller P. 2006. Structural and thermodynamical properties of CuII amyloid-beta16/28 complexes associated with Alzheimer's disease. J. Biol. Inorg. Chem. 11, 1024-1038.
14. Kozin S. A., Zirah S., Rebuffat S., Hoa G. H., Debey P. 2001. Zinc binding to Alzheimer's Abeta(1-16) peptide results in stable soluble complex. Biochem. Biophys. Res. Commun. 285, 959-964.
15. Mekmouche Y., Coppel Y., Hochgrafe K., Guilloreau L., Talmard C., Mazarguil H., Faller P. 2005. Characterization of the ZnII binding to the peptide amyloid-beta1-16 linked to Alzheimer's disease. Chembiochem. 6, 1663-1671.
16. Zirah S., Stefanescu R., Manea M., Tian X., Cecal R., Kozin S. A., Debey P., Rebuffat S., Przybylski M. 2004. Zinc binding agonist effect on the recognition of the betaamyloid (4-10) epitope by anti-beta-amyloid antibodies. Biochem. Biophys. Res. Commun. 321, 324-328.
17. Tsvetkov F. O., Makarov A. A., Archakov A. I., Kozin S. A. 2009. Effect of isomerization of aspartate-7 on the binding of copper (II) ion by the beta-amyloid peptide. Biofizika. 54, 197-201.
18. Tsvetkov P. O., Popov I. A., Nikolaev E. N., Archakov A. I., Makarov A. A., Kozin S. A. 2008. Isomerization of the Asp7 residue results in zincinduced oligomerization of Alzheimer's disease amyloid beta(1-16) peptide. Chembiochem. 9, 1564-1567.
19. Lovell M. A., Robertson J. D., Teesdale W. J., Campbell J. L., Markesbery W. R. 1998. Copper, iron and zinc in Alzheimer's disease senile plaques. J. Neurol. Sci. 158, 47-52.
20. Miller Y., Ma B., Nussinov R. 2010. Zinc ions promote Alzheimer Abeta aggregation via population shift of polymorphic states. Proc. Natl. Acad. Sci. USA. 107, 9490-9495.
21. Shivers B. D., Hilbich C., Multhaup G., Salbaum M., Beyreuther K., Seeburg P. H. 1988. Alzheimer's disease amyloidogenic glycoprotein: Expression pattern in rat brain suggests a role in cell contact. EMBO J. 7, 1365-1370.
22. Billeter M., Wagner G., Wuthrich K. 2008. Solution NMR structure determination of proteins revisited. J. Biomol. NMR. 42, 155-158.
23. Clore G. M., Brunger A. T., Karplus M., Gronenborn A. M. 1986. Application of molecular dynamics with interproton distance restraints to three-dimensional protein structure determination. A model study of crambin. J. Mol. Biol. 191, 523-551.
24. Brünger A. T. 1992. X-PLOR: A System for X-ray Crystallography and NMR, 17th ed. New Haven, Connecticut: Yale Univ. Press.
25. Brunger A. T., Adams P. D., Clore G. M., DeLano W. L., Gros P., Grosse-Kunstleve R. W., Jiang J. S., Kuszewski J., Nilges M., Pannu N. S., Read R. J., Rice L. M., Simonson T., Warren G. L. 1998. Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr. D Biol. Crystallogr. 54, 905-921.
26. Linge J. P., Habeck M., Rieping W., Nilges M. 2003. ARIA: Automated NOE assignment and NMR structure calculation. Bioinformatics. 19, 315-316.
27. Linge J. P., Nilges M. 1999. Influence of non-bonded parameters on the quality of NMR structures: A new force field for NMR structure calculation. J. Biomol. NMR. 13, 51-59.
28. Rieping W., Habeck M., Bardiaux B., Bernard A., Malliavin T. E., Nilges M. 2007. ARIA2: Automated NOE assignment and data integration in NMR structure calculation. Bioinformatics. 23, 381-382.
29. Guntert P. 2004. Automated NMR structure calculation with CYANA. Methods Mol. Biol. 278, 353-378.
30. Bardiaux B., Malliavin T. E., Nilges M., Mazur A. K. 2006. Comparison of different torsion angle approaches for NMR structure determination. J. Biomol. NMR. 34, 153-166.
31. Hornak V., Abel R., Okur A., Strockbine B., Roitberg A., Simmerling C. 2006. Comparison of multiple Amber force fields and development of improved protein backbone parameters. Proteins. 65, 712-725.
32. Linge J. P., Williams M. A., Spronk C. A., Bonvin A. M., Nilges M. 2003. Refinement of protein structures in explicit solvent. Proteins. 50, 496-506.
33. van der Spoel D., Lindahl E., Hess B., Groenhof G., Mark A. E., Berendsen H. J. 2005. GROMACS: Fast, flexible, and free. J. Comput. Chem. 26, 1701-1718.
34. Wuthrich K. 1986. NMR of Proteins and Nucleic Acids. NY: Wiley.
35. Oh D., Shin S. Y., Kang J. H., Hahm K. S., Kim K. L., Kim Y. 1999. NMR structural characterization of cecropin A(1-8)-magainin 2(1-12) and cecropin A (1-8)-melittin (1-12) hybrid peptides. J. Pept. Res. 53, 578-589.
36. Hess B., van der Vegt N. F. 2006. Hydration thermodynamic properties of amino acid analogues: A systematic comparison of biomolecular force fields and water models. J. Phys. Chem. B. 110, 17616-17626.
37. Shen T., Wong C. F., McCammon J. A. 2001. Atomistic Brownian dynamics simulation of peptide phosphorylation. J. Am. Chem. Soc. 123, 9107-9111.
38. Laskowski R. A., Rullmannn J. A., MacArthur M. W., Kaptein R., Thornton J. M. 1996. AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR. J. Biomol. NMR. 8, 477-486.
39. Kuszewski J., Gronenborn A. M., Clore G. M. 1997. Improvements and extensions in the conformational database potential for the refinement of NMR and X-ray structures of proteins and nucleic acids. J. Magn. Reson. 125, 171-177.
40. Voelz V. A., Bowman G. R., Beauchamp K., Pande V. S. 2010. Molecular simulation of ab initio protein folding for a millisecond folder NTL9(1-39). J. Am. Chem. Soc. 132, 1526-1528.